CENPK orchestrates ovarian cancer progression via GOLPH3-Mediated activation of mTOR signaling
Molecular and Cellular Endocrinology · 2024
DOI: 10.1016/j.mce.2024.112253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Gaolian Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei Province, 434100, China. Hauptthemen laut MEDLINE: Cell Proliferation, Disease Progression, Gene Expression Regulation, Neoplastic, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Ovarian cancer stands as a formidable clinical challenge, with limited therapeutic options. This investigation delves into the intricate molecular mechanisms governing ovarian cancer progression and uncovers Centromere Protein K (CENPK) as a central figure in disease pathogenesis. Elevated CENPK levels within ovarian cancer tissues conspicuously align with adverse clinical outcomes, positioning CENPK as a promising prognostic biomarker. Deeper exploration reveals a direct transcriptional connection between CENPK and the E2F1 transcription factor and clearly establishes E2F1's role as the master regulator of CENPK expression in ovarian cancer. Our inquiry revealing a suppression of tumor-promoting signaling pathways, most notably the mTOR pathway, upon CENPK silencing. Intriguingly, CENPK renders ovarian cancer cells more responsive to the mTOR inhibitor rapamycin, introducing a promising avenue for therapeutic intervention. In summation, our study unravels the multifaceted role of CENPK in ovarian cancer progression. It emerges as a prognostic indicator, a pivotal mediator of cell proliferation and tumorigenicity, and a regulator of the mTOR pathway, shedding light on potential therapeutic avenues for this formidable disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei Province, 434100, China.
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China.
- School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China.
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China. Electronic address: jijing@jou.edu.cn.
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China. Electronic address: liubin@jou.edu.cn.
Zitieren
APA
Li, G., Shen, J., Cheng, W., Wang, X., Wang, D., Song, Y., Chen, Y., Li, X., Zhang, M., Ding, Y., Ma, X., Qian, Q., Zhang, G., Ji, J., & Liu, B. (2024). CENPK orchestrates ovarian cancer progression via GOLPH3-Mediated activation of mTOR signaling. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112253
Vancouver
Li G, Shen J, Cheng W, Wang X, Wang D, Song Y, et al. CENPK orchestrates ovarian cancer progression via GOLPH3-Mediated activation of mTOR signaling. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112253
BibTeX
@article{Li2024,
author = {Li, Gaolian and Shen, Jing and Cheng, Wenhao and Wang, Xiaoshuo and Wang, Dan and Song, Yizhuo and Chen, Yulu and Li, Xiuming and Zhang, Meiqi and Ding, Yuanyuan and Ma, Xinhui and Qian, Qilan and Zhang, Geng and Ji, Jing and Liu, Bin},
title = {CENPK orchestrates ovarian cancer progression via GOLPH3-Mediated activation of mTOR signaling},
journal = {Molecular and Cellular Endocrinology},
year = {2024},
doi = {10.1016/j.mce.2024.112253}
}
EUVIMED